8-K: OneMedNet Secures Up to $25M Equity Line with Yorkville
Material Definitive Agreement
OneMedNet Corporation has entered into a standby equity purchase agreement with YA II PN, Ltd. allowing for up to $25 million in potential capital raises over 36 months.
Summary
- OneMedNet Corporation has entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. (Yorkville).
- Under the SEPA, OneMedNet has the option to sell up to $25 million of its common stock to Yorkville.
- The agreement is effective for 36 months from July 1, 2026.
- Sales will occur at the Company's request, subject to conditions including an effective resale registration statement.
- Shares will be purchased at 97% of the market price, with the Company able to set a minimum acceptable price.
- There are limitations on the amount of shares Yorkville can purchase in each advance and in aggregate, not exceeding 4.99% beneficial ownership per advance and an Exchange Cap of 11,386,834 shares (19.99% of outstanding shares as of June 30, 2026), unless shareholder approval is obtained for issuances exceeding this cap.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral development. While it provides access to significant capital, the terms involve a discount to market price and potential for substantial dilution, which are common drawbacks of such agreements.
Positives
- Provides access to up to $25 million in potential capital, offering financial flexibility.
- The agreement allows the company to draw down funds as needed, providing strategic control over capital raises.
- The purchase price is set at 97% of the market price, which is a common structure for such agreements.
- The 36-month term provides a long-term financing option.
Negatives
- The purchase price is at a discount (3% below market price) to the prevailing market price.
- The potential for significant dilution exists if the company draws down the full amount, especially if executed at lower market prices.
- The Exchange Cap limits the amount that can be sold without shareholder approval, potentially hindering larger capital needs without further corporate action.
Risks
- Potential for significant dilution of existing shareholders' equity if the company utilizes the full $25 million facility.
- The market price of the common stock could be negatively impacted by the continuous sale of shares.
- The company's ability to raise capital is contingent on market conditions and the effectiveness of a resale registration statement.
- Yorkville's beneficial ownership is capped at 4.99% per advance, but the aggregate cap of 19.99% without shareholder approval could limit future flexibility.
Future Outlook
The company has secured a flexible financing option that allows it to raise up to $25 million over a 36-month period, subject to market conditions and the effectiveness of a resale registration statement. The ability to draw funds at its discretion provides a degree of control over future capital needs.
Management Comments
- The SEPA provides the Company with the option to sell shares to Yorkville at its request, subject to certain conditions.
- The Company may establish a minimum acceptable price in each advance below which it will not be obligated to make any sales to Yorkville.
Industry Context
StockSavvy.ai notes that standby equity purchase agreements are a common financing tool for companies, particularly those in growth phases or with fluctuating capital needs, to access capital without the immediate commitment of a traditional equity offering. This strategy can provide flexibility but also carries the risk of dilution.
Stakeholder Impact
- Shareholders: Potential for dilution of ownership percentage and earnings per share if the full $25 million is drawn down, especially if executed at lower market prices. However, it provides a capital source that could support future growth and value creation.
- Creditors: The capital raise could strengthen the company's financial position, potentially improving its ability to meet its obligations.
- Management: Gains flexibility in managing the company's capital structure and funding strategic initiatives.
Next Steps
- The Company must file a resale registration statement covering the shares of Common Stock issued under the SEPA.
- The Company may request advances under the SEPA from time to time following the effectiveness of the resale registration statement.
- The SEPA terminates on its 36-month anniversary.
Key Dates
| Date | Description |
|---|---|
| 2026-06-30 | Date as of which the number of outstanding shares of Common Stock was 56,952,652. |
| 2026-07-01 | Date of the earliest event reported (Entry into Material Definitive Agreement SEPA) and the effective date of the SEPA. |
Recommendation
holdThe filing indicates a potential capital raise with terms that include a discount to market price and significant dilution risk. While providing financial flexibility, the immediate impact on share price could be negative due to the potential for increased share count. A 'hold' recommendation is appropriate pending further clarity on the company's use of these funds and their impact on future performance.
Keywords
Standby Equity Purchase Agreement, SEPA, OneMedNet Corporation, ONMD, Yorkville, Capital Raise, Equity Financing, Dilution, SEC Filing, Form 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.